Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

YARON D LANGMAN

Allopathic & Osteopathic Physicians Internal Medicine Gastroenterology

NPI
1568622678
CMS profile
162167
Location
POMONA, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2021 · Entire year

$1,459.08

91 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2021 · entire year · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,459.08 91

By paying entity

PY2021 · entire year · sorted by reported total

Page 2 of 2; records 51–91 of 91 matching records. This page contains 41 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

YARON D LANGMAN

NPI 1568622678 · CMS profile ID 162167

Allopathic & Osteopathic Physicians / Internal Medicine / Gastroenterology

POMONA, NY

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–91 of 91 matching records. This page contains 41 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1568622678?year=2021&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
YARON D LANGMAN, NPI 1568622678, CMS profile ID 162167. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–91 of 91 matching records. This page contains 41 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1568622678?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
APA 7
IndustryPayments. (2026). YARON D LANGMAN, NPI 1568622678, CMS profile ID 162167. General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–91 of 91 matching records. This page contains 41 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1568622678?year=2021&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202.
Bluebook
YARON D LANGMAN, NPI 1568622678, CMS profile ID 162167, IndustryPayments, General Payments, PY2021; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–91 of 91 matching records. This page contains 41 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/0380bbeb-aea1-58b6-b708-829f92a48202. https://industrypayments.org/provider/npi-1568622678?year=2021&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2021

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2021 · Physicians and non-physician practitioners · CMS publication 2026-06-30

91 matching records · $1,459.08 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 91 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–91 of 91.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Gilead Sciences, Inc. $15.8806/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848226211 CMS
Janssen Biotech, Inc. $1.8706/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788395121 CMS
AbbVie Inc. $12.6606/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795225647 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.0206/09/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850374175 CMS
Janssen Biotech, Inc. $11.8306/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788395123 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $17.6405/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849961663 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.0105/26/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850405067 CMS
AbbVie Inc. $7.0005/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795225641 CMS
Gilead Sciences, Inc. $18.9605/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848226209 CMS
Ironwood Pharmaceuticals, Inc $22.0005/11/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855109943 CMS
EVOKE PHARMA, INC. $14.4605/05/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849329405 CMS
PFIZER INC. $14.1204/30/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832497948 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $16.5904/29/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850140021 CMS
AbbVie Inc. $13.0604/28/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795225635 CMS
AbbVie Inc. $13.9404/27/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795225629 CMS
Janssen Biotech, Inc. $14.2404/22/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788395133 CMS
AbbVie Inc. $22.6904/21/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795225623 CMS
Takeda Pharmaceuticals U.S.A., Inc. $5.6404/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820037927 CMS
Gilead Sciences, Inc. $18.3604/15/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 848226207 CMS
Ironwood Pharmaceuticals, Inc $20.9504/08/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 855132715 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $20.8804/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850333169 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $14.4504/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850396885 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1.2804/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820037917 CMS
Takeda Pharmaceuticals U.S.A., Inc. $12.7404/07/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820037923 CMS
Janssen Biotech, Inc. $19.8503/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788395131 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.7603/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850239559 CMS
RedHill Biopharma Inc. $16.2603/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 799929511 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.5903/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850003389 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $8.5003/17/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850142693 CMS
AbbVie Inc. $18.5803/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795225617 CMS
Janssen Biotech, Inc. $12.7103/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788395139 CMS
Nestle HealthCare Nutrition Inc. $25.0002/25/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 820919173 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $12.2102/24/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850309013 CMS
Janssen Scientific Affairs, LLC $39.9902/23/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788395141 CMS
AbbVie Inc. $9.5002/16/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795225611 CMS
PFIZER INC. $13.6102/04/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 832496365 CMS
Janssen Biotech, Inc. $10.8302/03/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 788395125 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $10.6501/20/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 850067919 CMS
AbbVie Inc. $13.9401/13/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 795225605 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $13.7601/12/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849943935 CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC $19.3501/06/2021 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 849947391 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $548.59 37
PY2020 $631.86 44
PY2021 $1,459.08 91
PY2022 $1,616.40 86
PY2023 $2,338.82 121
PY2024 $2,058.76 115
PY2025 $1,860.25 109

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2020 Recipient $54.44 2
PY2020 Principal investigator $6,705.00 6
PY2019 Recipient $841.39 1
PY2019 Principal investigator $25,330.94 4

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

8 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Allergan, Inc. $1,025.00 09/15/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS. No dispute reported 06/30/2026 721297139
Principal investigator 1 Allergan, Inc. $225.00 04/28/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS. No dispute reported 06/30/2026 721273339
Principal investigator 1 Allergan, Inc. $1,500.00 04/01/2020 Non-covered Recipient Entity
GEN1 RESEARCH LLC
AURORA: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis No dispute reported 06/30/2026 721268397
Principal investigator 1 Allergan, Inc. $1,000.00 04/01/2020 Non-covered Recipient Entity
GEN1 RESEARCH LLC
AURORA: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Adult Subjects with Nonalcoholic Steatohepatitis No dispute reported 06/30/2026 721268409
Principal investigator 1 Allergan, Inc. $955.00 03/10/2020 Non-covered Recipient Entity
COPERNICUS GROUP INCORPORATED DBA COPERNICUS GROUP
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CENICRIVIROC FOR THE TREATMENT OF LIVER FIBROSIS IN ADULT SUBJECTS WITH NONALCOHOLIC STEATOHEPATITIS. No dispute reported 06/30/2026 721262459
Principal investigator 1 Eli Lilly and Company $2,000.00 03/09/2020 Non-covered Recipient Entity
GEN1 RESEARCH LLC
A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL, PLACEBO-CONTROLLED INDUCTION STUDY OF MIRIKIZUMAB IN CONVENTIONAL-FAILED AND BIOLOGIC-FAILED PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (LUCENT 1) No dispute reported 06/30/2026 728736377
Recipient Eli Lilly and Company $28.24 02/26/2020 Covered Recipient Physician A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL-ARM, PLACEBO-CONTROLLED MAINTENANCE STUDY OF MIRIKIZUMAB IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (LUCENT 2) No dispute reported 06/30/2026 728726291
Recipient Eli Lilly and Company $26.20 02/25/2020 Covered Recipient Physician A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PARALLEL, PLACEBO-CONTROLLED INDUCTION STUDY OF MIRIKIZUMAB IN CONVENTIONAL-FAILED AND BIOLOGIC-FAILED PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS (LUCENT 1) No dispute reported 06/30/2026 728724145